Prognostic value ofKRASgenotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to extension of metastatic disease

✍ Scribed by Gemma Bruera, Katia Cannita, Daniela Di Giacomo, Aude Lamy, Giancarlo Troncone, Antonella Dal Mas, Gino Coletti, Thierry Frébourg, Jean Christophe Sabourin, Mario Tosi, Corrado Ficorella, Enrico Ricevuto

• Book ID: 119907200
• Publisher: BioMed Central
• Year: 2012
• Tongue: English
• Weight: 234 KB
• Volume: 10
• Category: Article
• ISSN: 1741-7015
• DOI: 10.1186/1741-7015-10-135